After Oppenheimer and Barclays gave Orchard Therapeutics PLC (NASDAQ: ORTX) a Buy rating last month, the company received another Buy,
Category: Healthcare
Ladenburg Thalmann & Co. Sticks to Their Buy Rating for Achieve Life Sciences Inc (ACHV)
In a report released today, Michael Higgins from Ladenburg Thalmann & Co. maintained a Buy rating on Achieve Life Sciences
Aimmune Therapeutics (AIMT) Receives a Buy from Wedbush
In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on Aimmune Therapeutics (AIMT – Research Report),
Cowen & Co. Initiates a Buy Rating on Argenx Se (ARGX)
In a report issued on September 13, Yaron Werber from Cowen & Co. initiated coverage with a Buy rating on
Inmune Bio Inc (INMB) Gets a Buy Rating from Maxim Group
In a report issued on September 13, Jason McCarthy from Maxim Group maintained a Buy rating on Inmune Bio Inc
The Corp VP,Quality&Transformation of Integra Lifesciences (NASDAQ: IART) is Selling Shares
Today, the Corp VP,Quality&Transformation of Integra Lifesciences (IART – Research Report), Joseph Vinhais, sold shares of IART for $57.98K. Following
Cowen & Co. Reaffirms Their Buy Rating on G1 Therapeutics Inc (GTHX)
In a report released today, Chris Shibutani from Cowen & Co. maintained a Buy rating on G1 Therapeutics Inc (GTHX